Published in Immunology on May 01, 1989
Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid. Infect Immun (1992) 1.01
Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies. Infect Immun (1992) 0.82
Outer membrane protein binding sites of complement component 3 during opsonization of Haemophilus influenzae. Infect Immun (1993) 0.79
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A simplified method for cyanogen bromide activation of agarose for affinity chromatography. Anal Biochem (1974) 13.32
The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys (1969) 6.55
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1983) 4.05
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology (1977) 2.73
Experimental Haemophilus influenzae type b meningitis: immunological investigation of the infant rat model. Infect Immun (1978) 2.46
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Antigenic heterogeneity of outer membrane proteins of nontypable Haemophilus influenzae is a basis for a serotyping system. Infect Immun (1985) 1.85
Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia. Infect Immun (1983) 1.78
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1984) 1.40
Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis. Infect Immun (1976) 1.29
Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity. J Infect Dis (1988) 1.22
A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, phagocytosis and complement consumption. J Immunol Methods (1985) 1.14
Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine. Infect Immun (1985) 1.09
Decreased protective efficacy of reduced and alkylated human immune serum globulin in experimental infection with Haemophilus influenzae type b. Infect Immun (1985) 1.01
Amidation of C3 at the thiolester site: stimulation of chemiluminescence and phagocytosis by a new inflammatory mediator. J Immunol (1985) 0.98
Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination. J Infect Dis (1986) 0.92
The intrinsic affinity constant (K) of anticapsular antibody to oligosaccharides of Haemophilus influenzae type b. J Immunol (1988) 0.90
Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence. J Clin Microbiol (1981) 0.85
Influence of antibody and complement components on phagocytosis and chemiluminescence of macrophages. Immunobiology (1985) 0.83
Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential. Immunology (1986) 0.82
Haemophilus influenzae type b opsonins of intravenous immunoglobulins. J Clin Immunol (1987) 0.81